Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

lenalidomide

  • Open Access
    Evaluation of the Time to Onset and Outcome of Lenalidomide-induced Thrombosis and Embolism Using Spontaneous Reporting Database
    JUNYA SATO, NARU YAMAMOTO, YUKA KAWAHARA, TADASHI SHIMIZU and MAYAKO UCHIDA
    In Vivo May 2023, 37 (3) 1246-1252; DOI: https://doi.org/10.21873/invivo.13201
  • You have access
    Safety and Effectiveness of Ixazomib Dose-escalating Strategy in Ixazomib-Lenalidomide-Dexamethasone Treatment for Relapsed/Refractory Multiple Myeloma
    YASUKATA OHASHI, MEGUMI YATABE, DAISUKE NIIJIMA, KENTARO TANI, CHIAKI OGAWA, YUTAKA YACHI, TOSHIYA KAGOO, SAIGEN BOKU, HIRONORI UENO, TAKAHIRO YANO, KOJI HIGAI and AKIHIRO YOKOYAMA
    In Vivo September 2020, 34 (5) 2821-2828; DOI: https://doi.org/10.21873/invivo.12108
In Vivo

© 2026 In Vivo

Powered by HighWire